Corynebacterium
New Corynebacterium research from University of New Mexico, Medical Department discussed
Published in TB and Outbreaks Week, September 2nd, 2008
"At present the cost of producing therapeutic monoclonal antibodies is between $1,000 to $6,000 per gram. The need to administer antibodies parenterally at frequent intervals further drives the cost of this treatment. Here we present an antibody delivery system, termed paratransgenesis, with the potential to overcome these limitations. The paratransgenic approach involves genetically transforming a commensal or symbiont...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- DOE/Brookhaven National Laboratory
Addiction treatment proves successful in animal weight loss study - Joslin Diabetes Center
Joslin study identifies protein that produces 'good' fat - NIH/National Institute of Allergy and Infectious Diseases
Leishmaniasis parasites evade death by exploiting the immune response to sand fly bites - Immunization
Vaxfectin(R)-formulated Measles DNA Vaccine Could Address Unmet Need for Infants - Aneurysm
Research reports on aneurysm from S. Kannoth and colleagues provide new insights - Bird Flu
Reports on bird flu findings from Chulalongkorn University provide new insights - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
